CDKN3 and cancer: The studies in Fig. 1 show that the p21Cip1 cyclin-dependent kinase inhibitor level is markedly increased in ACTL6A knockdown and knockout cells, suggesting that p21Cip1 may have a role in suppressing the cancer phenotype.